States across the U.S. are instituting measures
to prevent hoarding of malaria drugs hydroxychloroquine and chloroquine
in an effort to maintain supply amid acute demand from pharmacies and
COVID-19 patients.
At least 20 states have implemented emergency
restrictions or guidelines aimed at easing pressure on availability for
autoimmune patients. Some are limiting the size of prescriptions and/or
asking pharmacists to ensure that patients have tested positive for the
virus before filling scripts. Supplies of the drugs were already running
low last month.
Neither medicine has been proven to work against
COVID-19, but a number of studies are in process. Doctors are adding
them to standard-of-care treatment and have seen, in certain cases, some
effectiveness at shortening recovery time. Both work in the immune
system by preventing flare-ups, a condition seen in some severely ill
COVID-19 patients (cytokine storm).
Certain drug makers have donated millions of doses and others are ramping up production.
https://seekingalpha.com/news/3558453-malaria-drugs-in-high-demand-amid-covidminus-19
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.